loader2
Login Open ICICI 3-in-1 Account

Dec 12, 2025


Category

Others

AUM (Cr.)

1,033.98

Exit Load (%)

0.00

Min Inv Lumpsum

1,000

Expense Ratio

0.21

Sharpe Ratio

2.63

Beta Ratio

0.00

Fund Manager

Jitendra Tolani

Inception Date

Jul 06, 2021

Risk Level

Very High

Investment Objective

The investment objective of the scheme is to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme will be achieved.

Invest Now

Return Calculator

Investment Type

SIP Lumpsum

Company

  • periodic returns
  • Peer Comparison
Returns Type 1 Month (%) 6 Months (%) 1 Year (%) 3 Years (%) 5 Years (%) Since Inception (%)
Scheme - Nippon India Nifty Pharma ETF 0.94 3.89 3.12 21.97 0 11.5
Benchmark - Nifty Pharma TRI 0.95 4.02 3.34 22.28 13.87 0
Category Average - BEST ETFS/INDEX 1.55 11.03 14.39 17.96 16.17 15.06
Category Rank 3/2 3/2 3/2 3/2 1/2 2/2
Fund Name Nav () Chg (%) 1Y Return(%) 3Y Return(%) 5Y Return(%) AUM ( in Crs) Exp. Ratio (%) Min.Invst() Action
Tata Silver ETF 19.2256 3.61 107.03 0.00 0.00 1,382.84 0.44 100.00 invest
Tata Gold ETF 12.9948 3.05 68.60 0.00 0.00 2,210.10 0.40 100.00 invest
ICICI Pru Silver ETF 192.7664 2.86 103.50 39.63 0.00 10,733.25 0.40 100.00 invest
UTI-Silver Exchange Traded Fund 188.7624 2.86 106.51 0.00 0.00 957.99 0.53 5,000.00 invest
Mirae Asset NYSE FANG+ ETF 143.4684 -2.33 28.71 53.15 0.00 3,616.54 0.65 5,000.00 invest

Asset Allocation

Val (Cr.) Allocation (%)

Top sectors

AUM in Cr.

top holdings

Company Name As on Date Invested Amt (Cr) % Portfolio Weight Change (%)
(Invested Amt.)
4 Months Trends
Equity-Sun Pharma.Inds. Nov 30, 2025 239.56 23.17 5.59
Equity-Cipla Nov 30, 2025 106.91 10.34 -0.58
Equity-Divi`s Lab. Nov 30, 2025 102.11 9.88 -6.31
Equity-Dr Reddy`s Labs Nov 30, 2025 95.19 9.21 2.45
Equity-Lupin Nov 30, 2025 62.53 6.05 3.38
Equity-Laurus Labs Nov 30, 2025 49.74 4.81 5.42
Equity-Torrent Pharma. Nov 30, 2025 48.31 4.67 1.88
Equity-Aurobindo Pharma Nov 30, 2025 42.59 4.12 5.00
Equity-Alkem Lab Nov 30, 2025 39.73 3.84 0.62
Equity-Glenmark Pharma. Nov 30, 2025 36.34 3.51 0.22

latest news

Nippon India MF announces change in benchmark index under its scheme

Nippon India Mutual Fund has announced change in the benchmark of Nippon In...

Oct 20, 2025 12:09

Nippon India Mutual Fund announces change in Key Personnel

Nippon India Mutual Fund has announced the Mr. Soma Sankara Prasad has been...

Oct 16, 2025 10:08

Nippon India Silver ETF Fund of Fund temporary Suspension

Nippon India Mutual Fund has decided to limit the subscriptions in Nippon I...

Oct 15, 2025 11:04

Nippon India Balanced Advantage Fund announces Income Distribution cum Capital Withdrawal (IDCW)

Nippon India Mutual Fund has announced 12 September 2025 as the record date...

Sep 10, 2025 09:20

Nippon India Mutual Fund announces change in Exit Load Structure

Nippon India Mutual Fund has announced change in exit load structure under ...

Aug 30, 2025 11:20

Nippon India Mutual Fund announces change in scheme name

Nippon India Mutual Fund has announced change in scheme name under the foll...

Aug 28, 2025 11:14

SCHEME DETAILS

AMC Name : Nippon India Mutual Fund
Fund Name : Nippon India Nifty Pharma ETF
Contact Persone : Jitendra Tolani
Registered Address : 4th Floor, Tower A, Peninsula Busines-s Park, Ganapatrao Kadam MargLower Parel (W), Mumbai - 400013.
Telephone No : 022-68087000/1860260111
Fax No. : 022-68087097
Email : customercare:nipponindiaim.in
Website : mf.nipponindiaim.com